|
97
|
348
|
3lhjA |
Crystal structure of p38a mitogen-activated protein kinase in complex with a pyrazolopyridinone inhibitor. |
|
110
|
348
|
3lffA |
Human p38 map kinase in complex with rl166 |
|
95
|
350
|
3lfdA |
Human p38 map kinase in complex with rl113 |
|
86
|
293
|
3lq8A |
Structure of the kinase domain of c-met bound to xl880 (gsk1363089) |
|
67
|
258
|
3lmhA |
Crystal structure of the alpha-kinase domain of myosin heavy chain kinase a complex with adp |
|
85
|
287
|
3lm0A |
Crystal structure of human serine/threonine kinase 17b (stk17b) |
|
103
|
350
|
3lfbA |
Human p38 map kinase in complex with rl98 |
|
107
|
341
|
3lltA |
Crystal structure of pf14_0431, kinase domain. |
|
78
|
322
|
3lq5A |
Structure of cdk9/cyclint in complex with s-cr8 |
|
89
|
284
|
3lm5A |
Crystal structure of human serine/threonine kinase 17b (stk17b) in complex with quercetin |
|
78
|
298
|
3lfqA |
Crystal structure of cdk2 with sar60, an aminoindazole type inhibitor |
|
128
|
347
|
3lq3A |
Crystal structure of human choline kinase beta in complex with phosphorylated hemicholinium-3 and adenosine nucleotide |
|
68
|
253
|
3lmiA |
Crystal structure of the inactive alpha-kinase domain of myosin heavy chain kinase a (d766a) complex with atp |
|
113
|
427
|
3lj2A |
Ire1 complexed with jak inhibitor i |
|
102
|
308
|
3lctA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
|
93
|
297
|
3lcdA |
Inhibitor bound to a dfg-in structure of the kinase domain of csf-1r |
|
113
|
327
|
3kxnA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor tetraiodobenzimidazole (k88) |
|
89
|
319
|
3lcoA |
Inhibitor bound to a dfg-out structure of the kinase domain of csf-1r |
|
106
|
337
|
3l9nA |
Crystal structure of pkab3 (pka triple mutant v123a, l173m, q181k) with compound 27 |
|
90
|
309
|
3ky2A |
Crystal structure of fibroblast growth factor receptor 1 kinase domain |
|
101
|
356
|
3kvxA |
Jnk3 bound to aminopyrimidine inhibitor, sr-3562 |
|
103
|
304
|
3lcsA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
|
103
|
308
|
3l9pA |
Crystal structure of the anaplastic lymphoma kinase catalytic domain |
|
109
|
326
|
3kxmA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor k74 |
|
82
|
264
|
3kxzA |
The complex crystal structure of lck with a probe molecule w259 |
|
92
|
271
|
3lckA |
The kinase domain of human lymphocyte kinase (lck), activated form (auto-phosphorylated on tyr394) |
|
107
|
340
|
3l9lA |
Crystal structure of pka with compound 36 |
|
85
|
305
|
3kxxA |
Structure of the mutant fibroblast growth factor receptor 1 |
|
125
|
408
|
3kvwA |
Crystal structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (dyrk2) in complex with an indirubin ligand |
|
194
|
642
|
3krwA |
Human grk2 in complex with gbetgamma subunits and balanol (soak) |
|
109
|
340
|
3l9mA |
Crystal structure of pkab3 (pka triple mutant v123a, l173m, q181k) with compound 18 |
|
89
|
308
|
3l8pA |
Crystal structure of cytoplasmic kinase domain of tie2 complexed with inhibitor cep11207 |
|
108
|
327
|
3kxhA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl-acetic acid (k66) |
|
160
|
464
|
3ku2A |
Crystal structure of inactivated form of cdpk1 from toxoplasma gondii, tgme49.101440 |
|
98
|
349
|
3l8xA |
P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor |
|
109
|
327
|
3kxgA |
Crystal structure of z. mays ck2 kinase alpha subunit in complex with the inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64) |
|
181
|
642
|
3krxA |
Human grk2 in complex with gbetgamma subunits and balanol (co-crystal) |
|
94
|
360
|
3l1sA |
3-aryl-4-(arylhydrazono)-1h-pyrazol-5-ones: highly ligand efficient and potent inhibitors of gsk3 |
|
82
|
307
|
3l8vA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a biarylamine based inhibitor |
|
87
|
274
|
3kulA |
Kinase domain of human ephrin type-a receptor 8 (epha8) |
|
76
|
264
|
3kl8A |
Camkiintide inhibitor complex |
|
112
|
348
|
3kq7A |
Structure of human p38alpha with n-[4-methyl-3-(6-{[2-(1-methylpyrrolidin-2-yl)ethyl]amino}pyridine-3-amido)phenyl]-2-(morpholin-4-yl)pyridine-4-carboxamide |
|
69
|
297
|
3kexA |
Crystal structure of the catalytically inactive kinase domain of the human epidermal growth factor receptor 3 (her3) |
|
92
|
318
|
3ka0A |
Mk2 complex with inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2-hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide |
|
82
|
237
|
3kreA |
Crystal structure of phosphoribosylaminoimidazole-succinocarboxamide synthase from ehrlichia chaffeensis at 1.8a resolution |
|
86
|
315
|
3kn5A |
Crystal structure of the c-terminal kinase domain of msk1 in complex with amp-pnp |
|
83
|
282
|
3kk9A |
Camkii substrate complex b |
|
78
|
268
|
3kmwA |
Crystal structure of the ilk/alpha-parvin core complex (mgatp) |
|
105
|
338
|
3kkvA |
Structure of pka with a protein kinase b-selective inhibitor. |
|
104
|
348
|
3kf7A |
Crystal structure of human p38alpha complexed with a triazolopyrimidine compound |
